Aignostics - Turning complex biomedical data into transformative …
Aignostics turns complex biomedical data into transformative insights for biopharma companies through development of AI-powered precision medicine for pathology throughout the drug development pipeline from target identification, to translational …
AIGNOSTICS – AI-powered precision diagnostics for pathology
We build robust IVDR-compliant AI models from multi-lab data, for H&E, IHC and multiplex IF. We work in close collaboration with pathologists from Charité and other leading institutes, as well as regulatory experts, and can deploy with our own platform.
Aignostics - LinkedIn
Oct 18, 2024 · AI-powered precision diagnostics for pathology | Aignostics combines proprietary access to multimodal clinical datasets, industry-leading AI technologies, and rigorous science to develop best-in...
Aignostics Secures $34 Million Series B to Enhance Precision …
Oct 29, 2024 · aignostics-logo. As precision medicine becomes more nuanced and complex, biopharmaceutical companies are increasingly turning to AI to enhance the utility, performance,...
About us - Aignostics
We are an interdisciplinary team focused on powering the next generation of precision medicine and advancing the fields of AI and pathology. Aignostics started in 2018 within the walls of Charité Berlin and the Berlin Institute of Health (BIH), based on years of research conducted by the pathology department of Charité, TU Berlin and ...
Platform - Aignostics
Aignostics Platform. We combine rich data access, leading technologies, and deep roots in science and engineering to generate key insights for precision medicine. OUR approach. Data Technology Science. Our approach is rooted in high-quality data.
Aignostics - Wellington
Aignostics develops key technologies that allow the generation of tissued-based biomarkers to drastically improve how complex diseases are diagnosed and treated. Aignostics specializes in AI-powered pathology, uniquely combining proprietary technology, its pathologist network, and comprehensive access to key data modalities to build bespoke AI ...
Aignostics Secures $34 Million Series B to Enhance Precision …
Oct 29, 2024 · The new funding will strengthen Aignostics' offerings for target ID, translational research, and companion diagnostics (CDx), and support several strategic initiatives, including:
Aignostics - Crunchbase Company Profile & Funding
Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of ...
Aignostics - Products, Competitors, Financials, Employees, …
Aignostics specializes in AI-powered precision medicine, focusing on the biopharmaceutical industry. The company offers insights by analyzing complex biomedical data, including histopathology, omics, and clinical outcomes, to support …
- Some results have been removed